Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GLP-1R Agonists on Cardiac Function in Obese Diabetics
NCT02042664Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2011
- Primary completion
- Jan 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of exenatide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Intracardiac triglyceride content at 3 years. Started Jan 2011; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02042664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042664.